Official reports confirmed developments regarding trump unveils plan for 200% tariff on generic medicines raising global trade concerns on Thursday in New Delhi. The proposed trade barrier sparked apprehension among international pharmaceutical exporters particularly Indian generic drug manufacturers.
Administrative officials confirmed that dedicated task forces have been assigned to review operational protocols and ensure full compliance with established regulatory frameworks.
Relevant government departments are expected to publish formal progress reports as administrative evaluations continue over the coming weeks.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources: